Shiva Mills manufactures and sells cotton yarn to textile producers and operates wind turbines to generate electricity for its own industrial use.
The company operates in a highly commoditized spinning industry with no evidence of pricing power, as reflected by negative net margins and low single-digit ROCE. While captive wind energy provides a minor cost offset, it does not constitute a structural competitive advantage capable of protecting returns.
Capital has been largely deployed into maintaining aging spinning infrastructure and wind assets that have failed to generate returns above the cost of capital. The company has suspended dividends due to persistent losses and high capital intensity relative to cash flow.
The company's slow decay culminated in a liquidity trap where stagnant revenue and sub-inflationary returns on capital finally exhausted the patience of the market. By failing to modernize beyond its aging spinning infrastructure, the firm was squeezed by rising input costs that its commoditized product line could not pass on to customers. The lack of a succession plan for the octogenarian leadership led to a strategic vacuum, while the unresolved legal liabilities and the messy legacy of the demerger—specifically the failure to secure title deeds—created a cloud of uncertainty that prevented any meaningful recapitalization or exit for minority shareholders.
RichFakir rates Shiva Mills Ltd's business quality as poor — 25/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Shiva Mills Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shiva Mills Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Shiva Mills Ltd's fair value is about ₹21 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →